Literature DB >> 20008722

Adverse events after pars plana vitrectomy among medicare beneficiaries.

Joshua D Stein1, David N Zacks, Daniel Grossman, Hilary Grabe, Mark W Johnson, Frank A Sloan.   

Abstract

OBJECTIVES: To assess the complication rates of pars plana vitrectomy (PPV) among older Americans and to determine whether rates of adverse events and additional operations have changed during the past decade.
METHODS: Claims data were reviewed to identify all adults aged 68 years or older in the 5% Medicare sample who underwent their first PPV during 1994-1995, 1999-2000, and 2004-2005. One-year rates of severe complications (endophthalmitis, suprachoroidal hemorrhage, or retinal detachment), less severe complications, receipt of an additional operation, and blindness were calculated and compared among the 3 groups using Cox regression. Analyses were adjusted for prior adverse events (during the previous 3 years), demographic characteristics, and comorbid conditions.
RESULTS: The 1994-1995, 1999-2000, and 2004-2005 cohorts had 3263, 5064, and 5263 patients, respectively. The 1-year severe complication rates did not differ among the 3 groups (range, 4.8%-5.5%). The hazard of a less severe complication or an additional operation was higher in the 2004-2005 cohort than in the earlier cohorts (P < .05 for all comparisons). The hazard of endophthalmitis was higher in black individuals (P = .07) and those of other races (P = .02) than in white patients.
CONCLUSIONS: During the past decade, rates of severe complications after PPV remained stable, but rates of less severe complications and subsequent operations increased. Future studies should explore the potential factors that explain these changes and the alarming elevated incidence of post-PPV endophthalmitis among nonwhite individuals.

Entities:  

Mesh:

Year:  2009        PMID: 20008722      PMCID: PMC3077099          DOI: 10.1001/archophthalmol.2009.300

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  50 in total

1.  Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).

Authors:  Lihteh Wu; María A Martínez-Castellanos; Hugo Quiroz-Mercado; J Fernando Arevalo; María H Berrocal; Michel E Farah; Mauricio Maia; José A Roca; Francisco J Rodriguez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

2.  Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy.

Authors:  Asheesh Tewari; Gaurav K Shah; Amy Fang
Journal:  Retina       Date:  2008-02       Impact factor: 4.256

3.  [Outcomes of 110 consecutive 25-gauge transconjunctival sutureless pars plana vitrectomies].

Authors:  J Guyomarch; M-N Delyfer; J-F Korobelnik
Journal:  J Fr Ophtalmol       Date:  2008-05       Impact factor: 0.818

4.  Acute endophthalmitis after 25-gauge sutureless vitrectomy.

Authors:  Nur Acar; Yaprak Banu Unver; Tuğrul Altan; Ziya Kapran
Journal:  Int Ophthalmol       Date:  2007-05-11       Impact factor: 2.031

5.  Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005.

Authors:  Joshua D Stein; David Ruiz; Daniel Belsky; Paul P Lee; Frank A Sloan
Journal:  Ophthalmology       Date:  2008-07       Impact factor: 12.079

6.  [Long-term results after pars plana vitrectomy with 25 gauge technique].

Authors:  A Lommatzsch; B Heimes; M Trieschmann; G Spital; D Pauleikhoff
Journal:  Ophthalmologe       Date:  2008-05       Impact factor: 1.059

7.  Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy.

Authors:  Michael M Lai; Alan J Ruby; Ramin Sarrafizadeh; Kate E Urban; Tarek S Hassan; Kimberly A Drenser; Bruce R Garretson
Journal:  Retina       Date:  2008-05       Impact factor: 4.256

8.  Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes.

Authors:  Ingrid U Scott; Harry W Flynn; Sundeep Dev; Saad Shaikh; Robert A Mittra; J Fernando Arevalo; Andres Kychenthal; Nur Acar
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

9.  Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study.

Authors:  Heinrich Heimann; Karl Ulrich Bartz-Schmidt; Norbert Bornfeld; Claudia Weiss; Ralf-Dieter Hilgers; Michael H Foerster
Journal:  Ophthalmology       Date:  2007-12       Impact factor: 12.079

10.  The safety and efficacy of transconjunctival sutureless 23-gauge vitrectomy.

Authors:  Moon Jung Kim; Kyu Hyung Park; Jeong Min Hwang; Hyung Gon Yu; Young Suk Yu; Hum Chung
Journal:  Korean J Ophthalmol       Date:  2007-12
View more
  23 in total

1.  Effect of Prior Anti-VEGF Injections on the Risk of Retained Lens Fragments and Endophthalmitis after Cataract Surgery in the Elderly.

Authors:  Paul Hahn; Arseniy P Yashkin; Frank A Sloan
Journal:  Ophthalmology       Date:  2015-08-13       Impact factor: 12.079

Review 2.  Retinal pigment epithelium transplantation: concepts, challenges, and future prospects.

Authors:  P Alexander; H A J Thomson; A J Luff; A J Lotery
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

3.  Intraocular Oxygen and Antioxidant Status: New Insights on the Effect of Vitrectomy and Glaucoma Pathogenesis.

Authors:  Carla J Siegfried; Ying-Bo Shui
Journal:  Am J Ophthalmol       Date:  2019-02-15       Impact factor: 5.258

4.  Novel probabilistic model of core vitreous traction using microsurgical vitrectomy tools.

Authors:  Jawchyng L Lue; Ramiro Ribeiro; Michael J Koss; Paulo Falabella; Rodrigo Brant; Mark S Humayun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-18       Impact factor: 3.117

5.  Severe adverse events after cataract surgery among medicare beneficiaries.

Authors:  Joshua D Stein; Daniel S Grossman; Kevin M Mundy; Alan Sugar; Frank A Sloan
Journal:  Ophthalmology       Date:  2011-06-02       Impact factor: 12.079

Review 6.  Use of health care claims data to study patients with ophthalmologic conditions.

Authors:  Joshua D Stein; Flora Lum; Paul P Lee; William L Rich; Anne L Coleman
Journal:  Ophthalmology       Date:  2014-01-14       Impact factor: 12.079

7.  Experimental evaluation of the viscoelasticity of porcine vitreous.

Authors:  Ali Aboulatta; Ahmed Abass; Ahmed Makarem; Ashkan Eliasy; Dong Zhou; Duo Chen; Xiaoyu Liu; Ahmed Elsheikh
Journal:  J R Soc Interface       Date:  2021-02-03       Impact factor: 4.118

8.  Recovery of visual function after administration of dabigatran etexilate.

Authors:  Carl-Ludwig Schönfeld; Marie Fischer; Peter Distelmaier; Sebastian Philipp; Patrick Paquet; Katharina Haller; Linda Meyer
Journal:  Case Rep Ophthalmol       Date:  2014-08-14

9.  Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease.

Authors:  Robert I Griffiths; Cynthia D O'Malley; Robert J Herbert; Mark D Danese
Journal:  BMC Med Res Methodol       Date:  2013-03-06       Impact factor: 4.615

10.  Massive suprachoroidal hemorrhage: Surgical management and outcome.

Authors:  Thomas Laube; Claudia Brockmann; Norbert Bornfeld
Journal:  GMS Ophthalmol Cases       Date:  2015-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.